{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:43:22Z","timestamp":1790214202851,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.urology.2011.07.1392","type":"journal-article","created":{"date-parts":[[2011,9,11]],"date-time":"2011-09-11T16:25:32Z","timestamp":1315758332000},"page":"1235-1239","source":"Crossref","is-referenced-by-count":47,"title":["Prevalence of Fluoroquinolone-resistant Escherichia coli Before and Incidence of Acute Bacterial Prostatitis After Prostate Biopsy"],"prefix":"10.1016","volume":"78","author":[{"given":"Satoru","family":"Minamida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyasu","family":"Tsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Kurosaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatsugu","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.07.1392_bib1","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/01.ju.0000061280.23447.29","article-title":"Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy","volume":"169","author":"Tal","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.07.1392_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/39.2.115","article-title":"Antibiotic prophylaxis for transrectal prostate biopsy","volume":"39","author":"Taylor","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0090-4295(98)00296-9","article-title":"Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy","volume":"52","author":"Kapoor","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.07.1392_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0090-4295(98)00313-6","article-title":"Variability in patient preparation for prostate biopsy among American urologists","volume":"52","author":"Shandera","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.07.1392_bib5","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1439-0272.2003.tb00868.x","article-title":"Antibiotic therapy\u2014rationale and evidence for optimal drug concentrations in prostatic and seminal fluid and in prostatic tissue","volume":"35","author":"Naber","year":"2003","journal-title":"Andrologia"},{"key":"10.1016\/j.urology.2011.07.1392_bib6","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1128\/AAC.28.5.716","article-title":"The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans","volume":"28","author":"Hooper","year":"1985","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib7","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/AAC.33.10.1655","article-title":"Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infections and prostatitis","volume":"33","author":"Wolfson","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib8","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.44.8.2046-2051.2000","article-title":"A population pharmacokinetic analysis of the penetration of the prostate by levofloxacin","volume":"44","author":"Drusano","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10156-007-0570-3","article-title":"Acute bacterial prostatitis after transrectal prostate needle biopsy: clinical analysis","volume":"14","author":"Shigehara","year":"2008","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib10","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.juro.2007.10.071","article-title":"The incidence of fluoroquinolone resistant infections after prostate biopsy\u2014are fluoroquinolones still effective prophylaxis?","volume":"179","author":"Feliciano","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.07.1392_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.urology.2009.07.1222","article-title":"Bacterial sepsis after prostate biopsy\u2014a new perspective","volume":"74","author":"Lange","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.07.1392_bib12","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1442-2042.2005.01058.x","article-title":"Efficacy and morbidity of transrectal ultrasound-guided 12-core biopsy for detection of prostate cancer in Japanese men","volume":"12","author":"Matsumoto","year":"2005","journal-title":"Int J Urol"},{"key":"10.1016\/j.urology.2011.07.1392_bib13","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.meegid.2010.10.011","article-title":"Blood stream infections caused by Acinetobacter ursingii in an obstetrics ward","volume":"11","author":"Horii","year":"2011","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.urology.2011.07.1392_bib14","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/AAC.00265-10","volume":"54","author":"Hawser","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib15","series-title":"Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement (NCCLS Document M100-S20)","year":"2010"},{"key":"10.1016\/j.urology.2011.07.1392_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Urologic Surgery Antimicrobial Prophylaxis Best Practice Policy Panel: best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.07.1392_bib17","author":"Heidenreich"},{"key":"10.1016\/j.urology.2011.07.1392_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0924-8579(01)00368-5","article-title":"Antimicrobial susceptibility of community-acquired uropathogens in northern Israel","volume":"18","author":"Colodner","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.urology.2011.07.1392_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jac\/dkg028","article-title":"An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project","volume":"51","author":"Kahlmeter","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3201\/eid0805.010204","article-title":"Trends in fluoroquinolone (ciprofloxacin) resistance in enterobacteriaceae from bacteremias, England and Wales, 1990-1999","volume":"8","author":"Livermore","year":"2002","journal-title":"Emerging Infect Dis"},{"key":"10.1016\/j.urology.2011.07.1392_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/46.2.223","article-title":"Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands","volume":"46","author":"Goettsch","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s10156-010-0174-1","article-title":"The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy","volume":"17","author":"Ishikawa","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib23","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.juro.2010.11.088","article-title":"Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy","volume":"185","author":"Liss","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.07.1392_bib24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0022-5347(05)64565-X","article-title":"Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk","volume":"168","author":"Griffith","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.07.1392_bib25","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1128\/AAC.35.2.256","article-title":"Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs Medical Center","volume":"35","author":"Muder","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.urology.2011.07.1392_bib26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.urology.2008.12.067","article-title":"Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy","volume":"74","author":"Ozden","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.07.1392_bib27","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1128\/AAC.45.4.1238-1243.2001","article-title":"Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species","volume":"45","author":"Aldridge","year":"2001","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511021340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511021340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T23:27:19Z","timestamp":1543534039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429511021340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0090429511021340"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.07.1392","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}